Compare Fulford India with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs UNICHEM LAB - Comparison Results

FULFORD INDIA     Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA UNICHEM LAB FULFORD INDIA/
UNICHEM LAB
 
P/E (TTM) x 398.8 62.8 635.2% View Chart
P/BV x 6.2 0.7 921.2% View Chart
Dividend Yield % 0.1 2.1 4.1%  

Financials

 FULFORD INDIA   UNICHEM LAB
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
UNICHEM LAB
Mar-19
FULFORD INDIA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs942292 322.6%   
Low Rs450182 247.3%   
Sales per share (Unadj.) Rs691.4167.7 412.4%  
Earnings per share (Unadj.) Rs11.5-3.6 -315.7%  
Cash flow per share (Unadj.) Rs15.45.9 258.5%  
Dividends per share (Unadj.) Rs2.004.00 50.0%  
Dividend yield (eoy) %0.31.7 17.0%  
Book value per share (Unadj.) Rs380.0372.3 102.1%  
Shares outstanding (eoy) m3.9070.38 5.5%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.01.4 71.2%   
Avg P/E ratio x60.7-65.3 -93.0%  
P/CF ratio (eoy) x45.339.9 113.6%  
Price / Book Value ratio x1.80.6 287.7%  
Dividend payout %17.4-110.2 -15.8%   
Avg Mkt Cap Rs m2,71416,680 16.3%   
No. of employees `0000.42.6 17.1%   
Total wages/salary Rs m5052,393 21.1%   
Avg. sales/employee Rs Th6,073.04,535.2 133.9%   
Avg. wages/employee Rs Th1,137.4919.8 123.7%   
Avg. net profit/employee Rs Th100.7-98.2 -102.5%   
INCOME DATA
Net Sales Rs m2,69611,801 22.8%  
Other income Rs m125984 12.7%   
Total revenues Rs m2,82212,785 22.1%   
Gross profit Rs m-46-835 5.6%  
Depreciation Rs m15674 2.3%   
Interest Rs m1075 12.6%   
Profit before tax Rs m54-600 -9.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m10-343 -2.8%   
Profit after tax Rs m45-256 -17.5%  
Gross profit margin %-1.7-7.1 24.3%  
Effective tax rate %17.757.3 30.9%   
Net profit margin %1.7-2.2 -76.6%  
BALANCE SHEET DATA
Current assets Rs m1,73820,384 8.5%   
Current liabilities Rs m5455,029 10.8%   
Net working cap to sales %44.3130.1 34.0%  
Current ratio x3.24.1 78.7%  
Inventory Days Days48105 46.3%  
Debtors Days Days4135 3.2%  
Net fixed assets Rs m129,023 0.1%   
Share capital Rs m39141 27.7%   
"Free" reserves Rs m1,44326,058 5.5%   
Net worth Rs m1,48226,199 5.7%   
Long term debt Rs m00-   
Total assets Rs m2,07731,496 6.6%  
Interest coverage x6.7-7.0 -96.3%   
Debt to equity ratio x00-  
Sales to assets ratio x1.30.4 346.6%   
Return on assets %2.6-0.6 -455.8%  
Return on equity %3.0-1.0 -309.2%  
Return on capital %4.3-2.0 -215.3%  
Exports to sales %069.4 0.0%   
Imports to sales %24.50-   
Exports (fob) Rs mNA8,188 0.0%   
Imports (cif) Rs m659NA-   
Fx inflow Rs m178,188 0.2%   
Fx outflow Rs m673596 112.9%   
Net fx Rs m-6567,592 -8.6%   
CASH FLOW
From Operations Rs m90-3,278 -2.7%  
From Investments Rs m105-2,860 -3.7%  
From Financial Activity Rs m-14-24 58.3%  
Net Cashflow Rs m181-4,690 -3.8%  

Share Holding

Indian Promoters % 0.0 50.1 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 15.1 25.2%  
FIIs % 0.1 3.0 3.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 31.7 66.9%  
Shareholders   4,783 20,176 23.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  ALEMBIC LTD  ALEMBIC PHARMA  AJANTA PHARMA  

Compare FULFORD INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 5-YR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS